Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 309

1.

Herpes simplex virus encephalitis in human UNC-93B deficiency.

Casrouge A, Zhang SY, Eidenschenk C, Jouanguy E, Puel A, Yang K, Alcais A, Picard C, Mahfoufi N, Nicolas N, Lorenzo L, Plancoulaine S, Sénéchal B, Geissmann F, Tabeta K, Hoebe K, Du X, Miller RL, Héron B, Mignot C, de Villemeur TB, Lebon P, Dulac O, Rozenberg F, Beutler B, Tardieu M, Abel L, Casanova JL.

Science. 2006 Oct 13;314(5797):308-12. Epub 2006 Sep 14.

3.

Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming.

Allan RS, Waithman J, Bedoui S, Jones CM, Villadangos JA, Zhan Y, Lew AM, Shortman K, Heath WR, Carbone FR.

Immunity. 2006 Jul;25(1):153-62.

4.

Migratory dendritic cells: sometimes simply ferries?

Randolph GJ.

Immunity. 2006 Jul;25(1):15-8.

5.

Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes.

Hosken N, McGowan P, Meier A, Koelle DM, Sleath P, Wagener F, Elliott M, Grabstein K, Posavad C, Corey L.

J Virol. 2006 Jun;80(11):5509-15.

6.
7.

Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects.

Sylwester AW, Mitchell BL, Edgar JB, Taormina C, Pelte C, Ruchti F, Sleath PR, Grabstein KH, Hosken NA, Kern F, Nelson JA, Picker LJ.

J Exp Med. 2005 Sep 5;202(5):673-85.

8.

Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs.

Yoneyama H, Matsuno K, Toda E, Nishiwaki T, Matsuo N, Nakano A, Narumi S, Lu B, Gerard C, Ishikawa S, Matsushima K.

J Exp Med. 2005 Aug 1;202(3):425-35.

10.

Expression of cutaneous lymphocyte-associated antigen and E-selectin ligand by circulating human memory CD4+ T lymphocytes specific for herpes simplex virus type 2.

González JC, Kwok WW, Wald A, McClurkan CL, Huang J, Koelle DM.

J Infect Dis. 2005 Jan 15;191(2):243-54. Epub 2004 Dec 15.

11.

CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions.

Suvas S, Azkur AK, Kim BS, Kumaraguru U, Rouse BT.

J Immunol. 2004 Apr 1;172(7):4123-32.

12.
13.

Immunodominance among herpes simplex virus-specific CD8 T cells expressing a tissue-specific homing receptor.

Koelle DM, Liu Z, McClurkan CL, Cevallos RC, Vieira J, Hosken NA, Meseda CA, Snow DC, Wald A, Corey L.

Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12899-904. Epub 2003 Oct 17.

14.

Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9.

Krug A, Luker GD, Barchet W, Leib DA, Akira S, Colonna M.

Blood. 2004 Feb 15;103(4):1433-7. Epub 2003 Oct 16.

15.
16.

Infections in patients with inherited defects in phagocytic function.

Andrews T, Sullivan KE.

Clin Microbiol Rev. 2003 Oct;16(4):597-621. Review.

17.

Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells.

Allan RS, Smith CM, Belz GT, van Lint AL, Wakim LM, Heath WR, Carbone FR.

Science. 2003 Sep 26;301(5641):1925-8.

18.

Herpes simplex virus type 2 induces rapid cell death and functional impairment of murine dendritic cells in vitro.

Jones CA, Fernandez M, Herc K, Bosnjak L, Miranda-Saksena M, Boadle RA, Cunningham A.

J Virol. 2003 Oct;77(20):11139-49.

19.
20.

Impacts of avidity and specificity on the antiviral efficiency of HIV-1-specific CTL.

Yang OO, Sarkis PT, Trocha A, Kalams SA, Johnson RP, Walker BD.

J Immunol. 2003 Oct 1;171(7):3718-24.

Supplemental Content

Support Center